The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world
Recommended Citation
Chakrabarti S, Parish M, Peterson C, et al. The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world. Journal of Clinical Oncology. 2023;41:105. doi:10.1200/JCO.2023.41.4_suppl.105
Type
Abstract
